"The U.S. Food and Drug Administration today approved Differin Gel 0.1% (adapalene), a once-daily topical gel for the over-the-counter (OTC) treatment of acne. Differin Gel 0.1% is approved for use in people 12 years of age and older.
Brevoxyl-4 Gel (benzoyl peroxide gel) and Brevoxyl-8 Gel are indicated for use in the topical treatment of mild to moderate acne vulgaris. Brevoxyl-4 Gel (benzoyl peroxide gel) or Brevoxyl-8 Gel may be used as an adjunct in acne treatment regimens including antibiotics, retinoic acid products, and sulfur/salicylic acid containing preparations.
DOSAGE AND ADMINISTRATION
Therapy may be initiated with either Brevoxyl-4 Gel (benzoyl peroxide gel) or Brevoxyl-8 Gel. The medication should be applied once or twice daily to the affected areas. Frequency of use should be adjusted to obtain the desired clinical response. Gentle cleansing of the affected areas prior to application of Brevoxyl-4 Gel (benzoyl peroxide gel) or Brevoxyl-8 Gel may be beneficial. Clinically visible improvement will normally occur by the third week of therapy. Maximum lesion reduction may be expected after approximately eight to twelve weeks of drug use. Continuing use of the drug is normally required to maintain a satisfactory clinical response. HOW SUPPLIED
Brevoxyl®-4 Gel is supplied in 42.5 g (1.5 oz) tubes NDC 0145-2374-06.
Brevoxyl®-8 Gel is supplied in 42.5 g (1.5 oz) tubes NDC 0145-2384-06.
Store at controlled room temperature 15°-30°C (59°- 86°F).
Stiefel Laboratories, Inc. Coral Gables, FL 33134. Rev. 1007This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 5/8/2009
Additional Brevoxyl Gel Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.